Aurobindo Pharma shares: Is this the best investment now?
Aurobindo Pharma shares have hit a 52-week high following USFDA approval.
Empowering You with Knowledge for a Healthier Life
Aurobindo Pharma shares have hit a 52-week high following USFDA approval.
FDA pre-approval inspection marks a significant milestone for CARBOGEN AMCIS, showcasing their commitment to quality.
Apixaban Oral Suspension receives tentative FDA approval, offering a promising option for patients.
Health Canada approval is a significant milestone for IMCIVREE® in managing obesity in patients aged 4 and older.
Maha FDA price review is a smart move welcomed by domestic medtech manufacturers.
Vera's IgA nephropathy drug is making headlines with positive data supporting its full approval.
Discover local in-home care services for personalized senior assistance.
Indian woman Moscow SOS highlights urgent plea for consular access.
Chennai latest news highlights CM Vijay's unveiled mega plans for the Assembly Complex and High Court, promising significant…
Forex trading has become a highly competitive financial environment where speed, strategy, and access to capital determine how…